{"id":"W2587616376","doi":"10.1016/j.clinthera.2017.01.007","title":"A Review of the Clinical Efficacy and Safety of Insulin Degludec and Glargine 300 U/mL in the Treatment of Diabetes Mellitus","year":2017,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Diabetes Management and Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"AstraZeneca","keywords":"Insulin degludec; Medicine; Insulin glargine; Glycemic; Hypoglycemia; Insulin; Diabetes mellitus; Type 1 diabetes; Type 2 Diabetes Mellitus; Internal medicine; Insulin analog; Insulin detemir; Endocrinology; Intensive care medicine; Human insulin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005587079,0.0003364434,0.003973153,0.0000835836,0.00005080722,0.0000128049,0.0006110573,0.0003881003,0.00001691532],"category_scores_gemma":[0.001138517,0.0001447254,0.001019605,0.0002794533,0.001598869,0.00002119564,0.0002188913,0.0006298658,0.000001968863],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002155819,"about_ca_system_score_gemma":0.0002514183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002497816,"about_ca_topic_score_gemma":0.000002757446,"domain_scores_codex":[0.9945104,0.001606388,0.002797493,0.0004064725,0.0004027041,0.0002765745],"domain_scores_gemma":[0.9908965,0.005993072,0.001374516,0.001504356,0.0001351663,0.00009645233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007265147,0.001641791,0.006546891,0.04704799,0.0009879963,0.000001982809,0.00003134974,1.092938e-8,7.504571e-8,0.00008199622,0.00005639104,0.9435309],"study_design_scores_gemma":[0.002653842,0.001868762,0.01560061,0.0733607,0.004078229,8.20827e-7,0.000006061132,0.000007991836,6.313107e-7,0.00006898178,0.9022401,0.000113264],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00183052,0.9936341,8.705914e-7,0.0008251395,0.0001657888,0.003075656,0.00003804349,0.000004557464,0.0004253174],"genre_scores_gemma":[0.0004446477,0.9985864,0.00008727853,0.0004556299,0.0001664452,0.00003061281,0.00002468598,0.0000303584,0.0001740061],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9434176,"threshold_uncertainty_score":0.5901729,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3637011875830971,"score_gpt":0.5317562355104855,"score_spread":0.1680550479273883,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}